HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CNC

Centene Corporation (S&P 500)

Healthcare — Healthcare Plans

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Buy 2.5 / 5 18 analysts
$63.91
$-0.17 (-0.27%)
Target: $65.67 (2.7%)
Sign in to add CNC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$31.56B
P/E Ratio (TTM)-
Forward P/E13.87
EPS (TTM)$-13.05
Dividend Yield-
Profit Margin-3.61%
Revenue Growth5.10%
ROE-26.04%
Debt/Equity76.05
Recommendation Buy 2.5
Analyst Target$65.67
Analysts18
Indexes S&P 500

Technical Indicators

RSI (14)40.6
Beta1.08
SMA 20$66.15
SMA 40$64.65
52-Week High$69.36
52-Week Low$25.08
50-Day Avg$63.33
200-Day Avg$46.10
Avg Volume$5.45M
Volume$12.19M

Performance Analysis

BULLISH

CNC shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 88% of its 52-week range.
~ RSI at 40.6 is in neutral territory.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 5.1% year-over-year.
- Operating at a loss with -3.6% margin.
+ Wall Street consensus is "Buy" from 18 analysts.
+ Average analyst target of $65.67 implies 2.7% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:00 UTC

Back to Screener Export Report